Share
Journal Information
Issue
Vol. 8. Issue 2.Pages 87-168 (April - June 2009)
In memoriam
Hepatology highlights
Concise review
Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD)
Francesco Vizzutti;, Umberto Arena;, Valerio Nobili;, Roberto Tarquini;, Marco Trappoliere;, Giacomo Laffi;, Fabio Marra;, Massimo Pinzani
Ann Hepatol. 2009;8:89-94
Open access
Hepatic encephalopathy, ammonia, glutamate, glutamine and oxidative stress
Abraham Lemberg, Maria Alejandra Fernández
Ann Hepatol. 2009;8:95-102
Open access
Current and future treatment options for HCV
Bernd Kronenberger, Stefan Zeuzem
Ann Hepatol. 2009;8:103-12
Open access
Original article
Prevalence of hepatitis C virus infection in patients with cardiomyopathy
Vijaya Boyella;, Ikenna Onyebueke;, Najabh Farraj;, Suzette Graham-Hill;, Cherif El Younis;, Nora V. Bergasa
Ann Hepatol. 2009;8:113-5
Open access
Common SPINK-1 mutations do not predispose to the development of non-alcoholic fatty liver disease
Nevin Oruc;, Omer Ozutemiz;, Ulus Salih Akarca;, Afig Berdeli;, Galip Ersoz;, Fulya Gunsar;, Zeki Karasu;, Tankut Ilter;, Yucel Batur
Ann Hepatol. 2009;8:116-9
Open access
Incidence and prognostic factors associated with biliary atresia in western India
Saket R. Sanghai;, Ira Shah;, Sushmita Bhatnagar;, Anuradha Murthy
Ann Hepatol. 2009;8:120-2
Open access
Adipokines in a group of mexican patients with nonalcoholic steatohepatitis
Linda E. Muñoz, Paula Cordero, Liliana Torres, Alma Y. Sauceda, Juan P. Flores, Jose J. Segura
Ann Hepatol. 2009;8:123-8
Open access
Subzero nonfreezing storage of rat hepatocytes using UW solution and 1,4-butanediol. II- functional testing on rewarming and gene expression of urea cycle enzymes
Edgardo E. Guibert, Luciana L. Almada, Maria E. Mamprin, Cristina Bellarosa, Maria Dolores Pizarro, Claudio Tiribelli, Joaquin V. Rodriguez
Ann Hepatol. 2009;8:129-33
Open access
Role of ursodeoxycholic acid in prevention of hepatotoxicity caused by amoxicillin-clavulanic acid in rats
Gamal A. El-Sherbiny, Ashraf Taye, Ihab T. Abdel-Raheem
Ann Hepatol. 2009;8:134-40
Open access
Pharmacokinetics of acemetacin and its active metabolite indomethacin in rats during acute hepatic damage and liver regeneration
Aracely E. Chávez-Piña;, Liliana Favari;, Gilberto Castañeda-Hernández
Ann Hepatol. 2009;8:141-7
Open access
Editorial
Why is transient elastography essential in hepatology?
Misael Uribe-Ramos;, Nahum Méndez-Sánchez
Ann Hepatol. 2009;8:148-9
Open access
Images in hepatology
Portal hypertensive enteropathy & capsule endoscopy
Anastasios Koulaouzidis, Sarah Douglas, JN Plevris
Ann Hepatol. 2009;8:150
Open access
Case report
Portal venous gas. Report of three cases
José-Luis Martínez;, Jorge González-Acosta
Ann Hepatol. 2009;8:151-5
Open access
Congenital choledochal cyst in an infant with cystic fibrosis
Parviz Tabatabaie, Gholam-Hossein Fallahi, Fatemeh Farahmand, Kambiz Eftekhari, Maedeh Ahmadi, Faezeh Ahmadi, Fatemeh Bazvand, Nima Rezaeil
Ann Hepatol. 2009;8:156-7
Open access
The use of sildenafil to treat portopulmonary hypertension prior to liver transplantation
Ian S.H. Cadden;, Erica D. Greanya;, Siegfried R. Erb;, Charles H. Scudamore;, Eric M. Yoshida
Ann Hepatol. 2009;8:158-61
Open access
Acute liver failure due to white phosphorus ingestion
Oscar Santos, Juan-Carlos Restrepo, Lina Velásquez, Jaime Castaño, Gonzalo Correa, Elsy Sepúlveda, Nora Yepes, Sergio Hoyos, ... Andrés Cárdenas
Ann Hepatol. 2009;8:162-5
Open access
Liver news elsewhere
Nitazoxanide for the treatment of chronic hepatitis C New opportunities but new challenges?
Ingmar Mederacke;, Heiner Wedemeyer
Ann Hepatol. 2009;8:166-8
Open access
Publish in
Annals of Hepatology
Special content about COVID-19
- Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study
- Matrix metalloproteinase-2 inducing COL1A1 synthesis via integrin alpha Ⅴ promotes invasion and metastasis of cholangiocarcinoma cells
- P-2 NASH IS IMPROVED THROUGH MODIFICATIONS IN H3K9 METHYLATION BY PIRFENIDONE ACTING AS JMJD2B DEMETHYLASE ANTAGONIST.
- O-2 EVALUATION OF RISK FACTORS AND PROGNOSIS OF HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION
Affiliated societies
